Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 4,884Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 45NOVARTIS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NILOTINIB HYDROCHLORIDE

US Patent Number : 9061029

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 22068

Patent Use Code : U-1374

Delist Requested :

Patent Use Description : TREATMENT OF PHILADELP...

Patent Expiration Date : 2032-04-07

blank

02

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NILOTINIB HYDROCHLORIDE

US Patent Number : 8389537

Drug Substance Claim :

Drug Product Claim :

Application Number : 22068

Patent Use Code : U-1374

Delist Requested :

Patent Use Description : TREATMENT OF PHILADELP...

Patent Expiration Date : 2026-07-18

blank

03

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NILOTINIB HYDROCHLORIDE

US Patent Number : 8389537

Drug Substance Claim :

Drug Product Claim :

Application Number : 22068

Patent Use Code : U-1374

Delist Requested :

Patent Use Description : TREATMENT OF PHILADELP...

Patent Expiration Date : 2026-07-18

blank

04

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NILOTINIB HYDROCHLORIDE

US Patent Number : 8415363

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22068

Patent Use Code : U-1407

Delist Requested :

Patent Use Description : TREATMENT OF NEWLY DIA...

Patent Expiration Date : 2026-07-18

blank

05

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NILOTINIB HYDROCHLORIDE

US Patent Number : 9061029

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 22068

Patent Use Code : U-1374

Delist Requested :

Patent Use Description : TREATMENT OF PHILADELP...

Patent Expiration Date : 2032-04-07

blank

06

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NILOTINIB HYDROCHLORIDE

US Patent Number : 8415363

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22068

Patent Use Code : U-1407

Delist Requested :

Patent Use Description : TREATMENT OF NEWLY DIA...

Patent Expiration Date : 2026-07-18

blank

07

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NILOTINIB HYDROCHLORIDE

US Patent Number : 9061029

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 22068

Patent Use Code : U-1374

Delist Requested :

Patent Use Description : TREATMENT OF PHILADELP...

Patent Expiration Date : 2032-04-07

blank

08

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NILOTINIB HYDROCHLORIDE

US Patent Number : 8415363

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 22068

Patent Use Code : U-1407

Delist Requested :

Patent Use Description : TREATMENT OF NEWLY DIA...

Patent Expiration Date : 2026-07-18

blank

09

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NILOTINIB HYDROCHLORIDE

US Patent Number : 9061029

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 22068

Patent Use Code : U-3231

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-04-07

blank

10

arrow
Fi Europe 2024
Not Confirmed
arrow
Fi Europe 2024
Not Confirmed

NILOTINIB HYDROCHLORIDE

US Patent Number : 9061029

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 22068

Patent Use Code : U-3231

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-04-07

blank